Feng Shen

784 total citations
25 papers, 639 citations indexed

About

Feng Shen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Feng Shen has authored 25 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Feng Shen's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Feng Shen is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Feng Shen collaborates with scholars based in China, United States and Canada. Feng Shen's co-authors include Manohar Ratnam, L E Gentry, Xin Wang, James H. Freisheim, Yifan Kang, Jin Wang, Weining Wu, Junhui Cui, Kuan Jiang and Tongle Zhi and has published in prestigious journals such as Nature Medicine, Biochemistry and Scientific Reports.

In The Last Decade

Feng Shen

25 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feng Shen China	13	373	281	103	89	58	25	639
M. Byrne United States	8	150 0.4×	196 0.7×	120 1.2×	80 0.9×	54 0.9×	9	615
Keitaro Yamane Japan	14	405 1.1×	247 0.9×	91 0.9×	67 0.8×	190 3.3×	17	840
Cynthia E. Wilkins-Port United States	14	245 0.7×	250 0.9×	162 1.6×	20 0.2×	59 1.0×	17	588
Hajime Hirano Japan	14	220 0.6×	166 0.6×	114 1.1×	51 0.6×	26 0.4×	36	536
Emerence Crompot Belgium	13	301 0.8×	115 0.4×	306 3.0×	52 0.6×	130 2.2×	19	734
Zenan Yuan China	6	284 0.8×	118 0.4×	80 0.8×	34 0.4×	70 1.2×	8	631
Erna Raja Japan	13	476 1.3×	111 0.4×	154 1.5×	31 0.3×	35 0.6×	17	628
Shengnan Zhao China	7	219 0.6×	82 0.3×	78 0.8×	104 1.2×	120 2.1×	8	669
Mitsuo Goto Japan	16	234 0.6×	87 0.3×	195 1.9×	40 0.4×	54 0.9×	58	606
Sebastian Kłosek Poland	10	168 0.5×	101 0.4×	129 1.3×	30 0.3×	54 0.9×	20	474

Countries citing papers authored by Feng Shen

Since Specialization

Citations

This map shows the geographic impact of Feng Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Shen more than expected).

Fields of papers citing papers by Feng Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Shen. The network helps show where Feng Shen may publish in the future.

Co-authorship network of co-authors of Feng Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Shen. A scholar is included among the top collaborators of Feng Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Shen. Feng Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Bo, Jinsheng Sun, Feng Shen, Wei Li, & Wenzhe Zhang. (2020). Mechanism of wellbore instability in continental shale gas horizontal sections and its water-based drilling fluid countermeasures. Natural Gas Industry B. 7(6). 680–688. 34 indexed citations

Zhao, Ziyin, et al.. (2020). Protective effect of the RNA-binding protein RBM10 in hepatocellular carcinoma.. PubMed. 24(11). 6005–6013. 9 indexed citations

Fan, Gang, et al.. (2020). Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR‐1271‐5p and upregulating FRS2. Thoracic Cancer. 11(8). 2178–2187. 17 indexed citations

Shen, Feng, et al.. (2019). Preoperative serum carcinoembryonic antigen elevation in stage I colon cancer: improved risk of mortality in stage T1 than in stage T2. International Journal of Colorectal Disease. 34(6). 1095–1104. 5 indexed citations

Shen, Feng & Xia Hong. (2019). Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching. International Journal of Colorectal Disease. 34(8). 1375–1383. 11 indexed citations

Shen, Feng, et al.. (2019). <p>The LncRNA XIRP2-AS1 predicts favorable prognosis in colon cancer</p>. OncoTargets and Therapy. Volume 12. 5767–5778. 13 indexed citations

Shen, Feng, et al.. (2018). Prognostic accuracy of different lymph node staging systems in rectal adenocarcinoma with or without preoperative radiation therapy. Japanese Journal of Clinical Oncology. 48(7). 625–632. 13 indexed citations

Wu, Lun, Feng Shen, Wei Liu, et al.. (2017). Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression. Experimental and Therapeutic Medicine. 13(6). 3529–3534. 11 indexed citations

Wu, Weining, Qi Hu, Er Nie, et al.. (2017). Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma. Scientific Reports. 7(1). 45029–45029. 106 indexed citations

10.

Guo, Qing, Jia He, Feng Shen, et al.. (2016). TCN, an AKT inhibitor, exhibits potent antitumor activity and enhances radiosensitivity in hypoxic esophageal squamous cell carcinoma in vitro and in vivo. Oncology Letters. 13(2). 949–954. 5 indexed citations

11.

Cai, Ke, et al.. (2015). Expression of miR-221 in colon cancer correlates with prognosis.. PubMed. 8(2). 2794–8. 36 indexed citations

12.

Wang, Jin, et al.. (2014). miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumor Biology. 35(5). 4859–4865. 49 indexed citations

13.

Wang, Jin, et al.. (2014). MiR-142-3p Functions as a Potential Tumor Suppressor in Human Osteosarcoma by Targeting HMGA1. Cellular Physiology and Biochemistry. 33(5). 1329–1339. 53 indexed citations

14.

Xia, Yong, Tao Xi, Kui Wang, et al.. (2012). A Case-Control Study of Correlation between Preoperative Serum AFP and Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy. Hepatogastroenterology. 59(119). 2248–54. 10 indexed citations

15.

Lin, Shibo, Zhangjun Cheng, Xin Shi, & Feng Shen. (2010). Construction and identification of recombinant lentiviral vector expressing shRNA of p120 catenin gene. Academic Journal of Second Military Medical University. 30(5). 553–557. 1 indexed citations

16.

Shen, Feng, et al.. (2009). Luciferase Therapeutic Microcapsules for Gene Therapy. Artificial Cells Blood Substitutes and Biotechnology. 37(6). 235–244. 2 indexed citations

17.

Li, Aijun, Meng-Chao Wu, Wen‐Ming Cong, Feng Shen, & Bing Yi. (2003). Spontaneous complete necrosis of hepatocellular carcinoma: a case report.. PubMed. 2(1). 152–4. 17 indexed citations

18.

Wu, Shuguang, Jing Ma, Chi‐Ming Che, et al.. (1998). Treatment of Hepatocellular Carcinoma with the Cellular Tumor Vaccines Generated by in Vitro Modification of Tumor Cells with Non Gene Transfer Approaches. Advances in experimental medicine and biology. 451. 283–293. 4 indexed citations

19.

Shen, Feng, et al.. (1997). Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies. Nature Medicine. 3(4). 451–455. 38 indexed citations

20.

Shen, Feng, et al.. (1997). [Experimental and clinical research of cytolytic T lymphocytes specific for hepatocellular carcinoma].. PubMed. 35(2). 95–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact